Can indole-based extracts prevent colorectal cancer via early apoptotic pathways?

Cancer Biology and Therapy

Volumn 9, Issue 5, 2010, Pages 380-382

  Toden, Shusuke ^a   Scherer, Benjamin L ^a   Clarke, Julie M ^a  

^a NONE

Author keywords

Apoptosis; Azoxymethane; Colorectal cancer; Tyrian purple

Indexed keywords

6 BROMOISATIN; INDOLE DERIVATIVE; MURICID EXTRACT; NATURAL PRODUCT; TYRIAN PURPLE; TYRIAN PURPLE PRECURSOR; TYRINDOLENINONE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER MODEL; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DNA DAMAGE; DRUG EFFECT; DRUG EFFICACY; NONHUMAN; NOTE; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; COLORECTAL NEOPLASMS; FEMALE; INDOLES; MICE; MICE, INBRED C57BL;

EID: 77953703795     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.5.11353     Document Type: Note

References (31)

1. Stewart BW, Kleihues P. World cancer report. Lyon: IARC, 2003.
2. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Lancet 2002; 360:861-8.
3. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005; 6:871-6.
4. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66:1191-308. (Pubitemid 11063920)
5. Johnson IT, Lund EK. Review article: nutrition, obesity and colorectal cancer. Aliment Pharmacol Ther 2007; 26:161-81.
6. Bellamy CO, Malcomson RD, Harrison DJ, Wyllie AH. Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol 1995; 6:3-16.
7. Watson AJ. Apoptosis and colorectal cancer. Gut 2004; 53:1701-9.
8. Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment? Mol Cancer Ther 2003; 2:573-80.
9. Hirose Y, Yoshimi N, Makita H, Hara A, Tanaka T, Mori H, et al. Early alterations of apoptosis and cell proliferation in azoxymethane-initiated rat colonic epithelium. Jpn J Cancer Res 1996; 87:575-82. (Pubitemid 26235547)
10. Dashwood RH, Suzui M, Nakagama H, Sugimura T, Nagao M. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res 1998; 58:1127-9. (Pubitemid 28183197)
11. De Filippo C, Caderni G, Bazzicalupo M, Briani C, Giannini A, Fazi M, et al. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats. Br J Cancer 1998; 77:2148-51. (Pubitemid 28263934)
12. Reddy BS. The fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev 2000; 9:239-47.
13. Hong MY, Chapkin RS, Morris JS, Wang N, Carroll RJ, Turner ND, et al. Anatomical site-specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model. Carcinogenesis 2001; 22:1831-5.
14. Hu Y, Martin J, Le Leu R, Young GP. The colonic response to genotoxic carcinogens in the rat: regulation by dietary fibre. Carcinogenesis 2002; 23:1131-7. (Pubitemid 34814770)
15. Hong MY, Chapkin RS, Wild CP, Morris JS, Wang N, Carroll RJ, et al. Relationship between DNA adduct levels, repair enzyme and apoptosis as a function of DNA methylation by azoxymethane. Cell Growth Differ 1999; 10:749-58.
16. Le Leu RK, Hu Y, Young GP. Effects of resistant starch and nonstarch polysaccharides on colonic luminal environment and genotoxin-induced apoptosis in the rat. Carcinogenesis 2002; 23:713-9. (Pubitemid 34567508)
17. Le Leu RK, Brown IL, Hu Y, Young GP. Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium and lumenal contents in rats. Carcinogenesis 2003; 24:1347-52.
18. Whitehead RH, Young GP, Bhathal PS. Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 1986; 27:1457-63.
19. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81:1031-64.
20. Westley CB, McIver CM, Abbott CA, Le Leu RK, Benkendorff K. Enhanced acute apoptotic response to azoxymethane-induced DNA damage in the rodent colonic epithelium by Tyrian purple precursors: a potential colorectal cancer chemopreventative. Cancer Biol Ther 2010; 9:371-78.
21. Cooksey CJ. Tyrian purple: 6,6′-dibromoindigo and related compounds. Molecules 2001; 6:736-69.
22. Benkendorff K, Bremner J, Davis A. Tyrian purple precursors in the ess masses of the Australian muricid, Dicathais orbitia: a possible deffensive role. J Chem Ecol 2000; 26:1037-50.
23. Vine KL, Locke JM, Ranson M, Benkendorff K, Pyne SG, Bremner JB. In vitro cytotoxicity evaluation of some substituted isatin derivatives. Bioorg Med Chem 2007; 15:931-8.
24. Kim SA, Kim YC, Kim SW, Lee SH, Min JJ, Ahn SG, et al. Antitumor activity of novel indirubin derivatives in rat tumor model. Clin Cancer Res 2007; 13:253-9.
25. Benkendorff K, McIver CM, Abbott CA. Bioactivity of the murex homeopathic remedy and of extracts from an australian muricid mollusc against human cancer cells. Evid Based Complement Alternat Med 2009; In press.
26. Sethi G, Ahn KS, Sandur SK, Lin X, Chaturvedi MM, Aggarwal BB, et al. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway. J Biol Chem 2006; 281:23425-35.
27. Kim DH, Lee J, Kim KN, Kim HJ, Jeung HC, Chung HC, et al. Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor. Biochem Biophys Res Commun 2007; 356:233-8.
28. Meijer L, Skaltsounis AL, Magiatis P, Polychrono poulos P, Knockaert M, Leost M, et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol 2003; 10:1255-66.
29. Lee JW, Moon MJ, Min HY, Chung HJ, Park EJ, Park EJ, et al. Induction of apoptosis by a novel indirubin-5-nitro-3′-monoxime, a CDK inhibitor, in human lung cancer cells. Bioorg Med Chem Lett 2005; 15:3948-52.
30. Symonds EL, Butler R, Omari TI. A mouse model for assessing the impact of ingested nutrients on gastric emptying rate. Clin Exp Pharmacol Physiol 2007; 34:132-3.
31. Hayat MA. Microscopy, immunohistochemistry and antigen retrieval. Methods for light and electron microscopy. In: Kuo J, ed. Principles and Techniques of Electron Microscopy, NY: Kluwer Academic/Plenium Publishers 2001; 233-47.